82_FR_57198 82 FR 56968 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

82 FR 56968 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

DEPARTMENT OF DEFENSE
Office of the Secretary

Federal Register Volume 82, Issue 230 (December 1, 2017)

Page Range56968-56968
FR Document2017-25899

The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel).

Federal Register, Volume 82 Issue 230 (Friday, December 1, 2017) 
[Federal Register Volume 82, Number 230 (Friday, December 1, 2017)]
[Notices]
[Page 56968]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-25899]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Assistant Secretary of Defense (Health Affairs), Department of 
Defense.

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce a Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (hereafter referred to as the Panel).

DATES: Open to the public on Thursday, January 4, 2018, from 9:00 a.m. 
to 12:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Captain Edward C. Norton, United 
States Navy, Designated Federal Official, Uniform Formulary Beneficiary 
Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 
22042-5101. Email Address: [email protected].

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., 
Appendix, as amended), the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of the Defense Health Agency, by 
the Pharmacy and Therapeutics Committee, regarding the Uniform 
Formulary.
    Meeting Agenda:

1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Weight Loss Agents
    b. Oncological Agents: Multiple Myeloma
    c. Prenatal Vitamins
4. Newly Approved Drugs Review
5. Pertinent Utilization Management Issues
6. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 CFR 102-3.140 through 102-3.165, and the availability of space, this 
meeting is open to the public. Seating is limited and will be provided 
only to the first 220 people signing-in. All persons must sign-in 
legibly.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel about its mission and/or the agenda to be 
addressed in this public meeting. Written statements should be 
submitted to the Panel's Designated Federal Officer (DFO). The DFO's 
contact information can be obtained in the FOR FURTHER INFORMATION 
CONTACT section.
    Written comments or statements must be received by the committee 
DFO at least five (5) business days prior to the meeting so that they 
may be made available to the Panel for its consideration prior to the 
meeting. The DFO will review all submitted written statements and 
provide copies to all the committee members.

    Dated: November 28, 2017.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2017-25899 Filed 11-30-17; 8:45 am]
 BILLING CODE 5001-06-P

56968 Federal Register / Vol. 82, No. 230 / Friday, December 1, 2017 / Notices 5510–00–NSH–0080—Stakes/Lath, Survey, DEPARTMENT OF DEFENSE 220 people signing-in. All persons must Wood sign-in legibly. 5510–00–NSH–0081—Stakes/Lath, Survey, Office of the Secretary Written Statements: Pursuant to 41 Wood CFR 102–3.140, the public or interested 5510–00–NSH–0082—Stakes/Lath, Survey, Uniform Formulary Beneficiary organizations may submit written Wood Advisory Panel; Notice of Federal statements to the membership of the 5510–00–NSH–0083—Stakes/Lath, Survey, Advisory Committee Meeting Panel about its mission and/or the Wood agenda to be addressed in this public AGENCY: Assistant Secretary of Defense 5510–00–NSH–0084—Stakes/Lath, Survey, meeting. Written statements should be (Health Affairs), Department of Defense. Wood submitted to the Panel’s Designated 5510–00–NSH–0085—Stakes/Lath, Survey, ACTION: Notice of Federal Advisory Committee meeting. Federal Officer (DFO). The DFO’s Wood contact information can be obtained in 5510–00–NSH–0086—Stakes/Lath, Survey, the FOR FURTHER INFORMATION CONTACT SUMMARY: The Department of Defense is Wood section. publishing this notice to announce a 5510–00–NSH–0087—Stakes/Lath, Survey, Federal Advisory Committee meeting of Written comments or statements must Wood the Uniform Formulary Beneficiary be received by the committee DFO at 5510–00–NSH–0088—Stakes/Lath, Survey, Advisory Panel (hereafter referred to as least five (5) business days prior to the Wood the Panel). meeting so that they may be made 5510–00–NSH–0089—Stakes/Lath, Survey, Wood DATES: Open to the public on Thursday, available to the Panel for its 5510–00–NSH–0090—Stakes/Lath, Survey, January 4, 2018, from 9:00 a.m. to 12:00 consideration prior to the meeting. The Wood p.m. DFO will review all submitted written 5510–00–NSH–0091—Stakes/Lath, Survey, ADDRESSES: Naval Heritage Center statements and provide copies to all the Wood Theater, 701 Pennsylvania Avenue NW., committee members. 5510–00–NSH–0092—Stakes/Lath, Survey, Washington, DC 20004. Dated: November 28, 2017. Wood FOR FURTHER INFORMATION CONTACT: Aaron Siegel, 5510–00–NSH–0093—Stakes/Lath, Survey, Captain Edward C. Norton, United Alternate OSD Federal Register Liaison Wood States Navy, Designated Federal Officer, Department of Defense. 5510–00–NSH–0094—Stakes/Lath, Survey, Official, Uniform Formulary Beneficiary [FR Doc. 2017–25899 Filed 11–30–17; 8:45 am] Wood Advisory Panel, 7700 Arlington BILLING CODE 5001–06–P 5510–00–NSH–0095—Stakes/Lath, Survey, Boulevard, Suite 5101, Falls Church, VA Wood 22042–5101. Email Address: 5510–00–NSH–0096—Stakes/Lath, Survey, dha.ncr.health-it.mbx.baprequests@ DEPARTMENT OF DEFENSE Wood mail.mil. 5510–00–NSH–0097—Stakes/Lath, Survey, Office of the Secretary Wood SUPPLEMENTARY INFORMATION: This 5510–00–NSH–0101—Stakes/Lath, Survey, meeting is being held under the Notice of a Pilot Program on Wood provisions of the Federal Advisory Medication Therapy Management 5510–00–NSH–0102—Stakes/Lath, Survey, Committee Act of 1972 (5 U.S.C., Under the TRICARE Program Wood Appendix, as amended), the 5510–00–NSH–0103—Stakes/Lath, Survey, Government in the Sunshine Act of AGENCY: Office of the Secretary, Wood 1976 (5 U.S.C. 552b, as amended), and Department of Defense. 5510–00–NSH–0104—Stakes/Lath, Survey, 41 CFR 102–3.140 and 102–3.150. ACTION: Notice of a Pilot Program. Wood Purpose of Meeting: The Panel will 5510–00–NSH–0105—Stakes/Lath, Survey, review and comment on SUMMARY: Per Section 726 of the Wood recommendations made to the Director National Defense Authorization Act 5510–00–NSH–0106—Stakes/Lath, Survey, of the Defense Health Agency, by the (NDAA) for Fiscal Year (FY) 2015, the Wood Pharmacy and Therapeutics Committee, Department of Defense (DoD) is Mandatory Source of Supply: Siskiyou regarding the Uniform Formulary. implementing a 2-year Pilot Program, Opportunity Center, Inc., Mt. Shasta, CA Meeting Agenda: ‘‘Pilot Program on Medication Therapy Contracting Activity: FOREST SERVICE, Management Under TRICARE Program’’. 1. Sign-In KLAMATH NATIONAL FOREST The Pilot Program will provide 2. Welcome and Opening Remarks NSN—Product Name: 8470–00–NSH–0030— Medication Therapy Management 3. Scheduled Therapeutic Class Reviews Improved Oxygen Harness (MTM) services to promote adherence (Comments will follow each agenda Mandatory Source of Supply: Employment and improve medication-related health item) Source, Inc., Fayetteville, NC a. Weight Loss Agents outcomes for TRICARE beneficiaries Contracting Activity: Army Contracting b. Oncological Agents: Multiple (Beneficiaries) with more than one Command—Aberdeen Proving Ground, Myeloma chronic medical condition and taking Natick Contracting Division. c. Prenatal Vitamins more than one medication. The Pilot 4. Newly Approved Drugs Review Program will be conducted in three Patricia Briscoe, 5. Pertinent Utilization Management types of pharmacy settings. The intent Deputy Director, Business Operations, Issues of this Pilot Program is to evaluate the sradovich on DSK3GMQ082PROD with NOTICES (Pricing and Information Management). 6. Panel Discussions and Vote feasibility and desirability of including MTM as part of the TRICARE Program. [FR Doc. 2017–25854 Filed 11–30–17; 8:45 am] Meeting Accessibility: Pursuant to 5 BILLING CODE 6353–01–P U.S.C. 552b, as amended, and 41 CFR DATES: The demonstration began on 102–3.140 through 102–3.165, and the October 1, 2016, and will continue for availability of space, this meeting is no less than two years. open to the public. Seating is limited FOR FURTHER INFORMATION CONTACT: Mr. and will be provided only to the first David W. Bobb, Defense Health Agency, VerDate Sep<11>2014 16:44 Nov 30, 2017 Jkt 244001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\01DEN1.SGM 01DEN1


Document Created: 2018-10-25 10:44:29
Document Modified: 2018-10-25 10:44:29
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of Federal Advisory Committee meeting.
DatesOpen to the public on Thursday, January 4, 2018, from 9:00 a.m. to 12:00 p.m.
ContactCaptain Edward C. Norton, United States Navy, Designated Federal Official, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA
FR Citation82 FR 56968 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR